Ingrid Bacher

Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders

T. George, D. Shytle, Becky S. Wu, 2009, Expert opinion on pharmacotherapy.

Channelling of substrate promiscuity of the skeletal-muscle ADP-ribosyl cyclase isoform.

M. Hohenegger, M. Kratzel, Andreas Zidar, 2004, The Biochemical journal.

RE: Smoking Tobacco and Collective Myopia

B. Hitsman, T. George, Ingrid Bacher, 2009 .

Nicotinic Receptor Mechanisms in Neuropsychiatric Disorders: Therapeutic Implications

T. George, K. A. Sacco, Andrea A. Woznica, 2010 .

Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking.

Alan A. Wilson, S. Houle, J. Sacher, 2011, Archives of general psychiatry.

Mechanisms Underlying the Comorbidity of Tobacco Use in Mental Health and Addictive Disorders

T. George, D. Morisano, J. Audrain-McGovern, 2009, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status

T. George, V. Wing, K. A. Sacco, 2011, Psychiatry Research.

Varenicline modulates spatial working memory deficits in smokers with schizophrenia

T. George, V. Wing, C. Wass, 2013, Schizophrenia Research.

High frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophrenia

Z. Daskalakis, T. George, V. Wing, 2012, Schizophrenia Research.

Treatment of co-morbid cocaine dependence in schizophrenia with topiramate

T. George, Sandra J. Cushing, Diana R. Blank, 2010, Schizophrenia Research.